Ascendis Pharma A (ASND) Receivables (2012 - 2026)
Ascendis Pharma A (ASND) recorded Receivables of $270.82 million in the quarter ended Jun 30, 2026, up 108.3% from $130.03 million a year earlier and up 12.3% from the prior quarter.
Powered by 
Analysis
Ascendis Pharma A (ASND) Receivables (2012 - 2026) Analysis & Trends
As of Dec 31, 2025, Ascendis Pharma A reported Receivables of $171.96 million, down 6.7% from the prior year.
- Annual Receivables has a five-year compound annual growth rate of 75.3% (years ended Dec 2020 to Dec 2025).
- Across earlier years, Receivables came in at $184.26 million in the year ended Dec 31, 2024 (+328.2%), $43.03 million in the year ended Dec 31, 2023 (+195.2%), $14.58 million in the year ended Dec 31, 2022 (-12.0%) and $16.56 million in the year ended Dec 31, 2021 (+59.3%).
- The figure for the quarter ended Jun 30, 2026 is the highest quarterly Receivables in data going back to the quarter ended Dec 31, 2012.
- On a year-over-year basis, Receivables rose in seven of the last eight quarters, with growth averaging 143.4%.
- Peak year-over-year performance for Receivables in the last five years was growth of 603.3% in the quarter ended Mar 31, 2022, against a decline of 64.8% in the quarter ended Sep 30, 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $241.22 million (quarter ended Mar 31, 2026), $177.17 million (quarter ended Dec 31, 2025) and $165.66 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Ascendis Pharma A | 14.26 Bn | 10.50 Bn | 362.22 Mn | 270.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 270.82 Mn |
| Mar 31, 2026 | 241.22 Mn |
| Dec 31, 2025 | 177.17 Mn |
| Sep 30, 2025 | 165.66 Mn |
| Jun 30, 2025 | 130.03 Mn |
| Mar 31, 2025 | 74.88 Mn |
| Dec 31, 2024 | 180.16 Mn |
| Sep 30, 2024 | 46.27 Mn |
| Jun 30, 2024 | 58.39 Mn |
| Mar 31, 2024 | 49.90 Mn |
| Dec 31, 2023 | 40.89 Mn |
| Sep 30, 2023 | 31.50 Mn |
| Jun 30, 2023 | 24.26 Mn |
| Mar 31, 2023 | 19.43 Mn |
| Dec 31, 2022 | 14.11 Mn |
| Sep 30, 2022 | 8.62 Mn |
| Jun 30, 2022 | 8.19 Mn |
| Mar 31, 2022 | 15.60 Mn |
| Dec 31, 2021 | 4.59 Mn |
| Sep 30, 2021 | 24.52 Mn |
API Access
Ascendis Pharma A Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=ASND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "ASND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=ASND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();